Clinical outcome and antimicrobial therapeutic drug monitoring for the treatment of infections in acute burn patients (2017)
- Authors:
- USP affiliated authors: SILVA JUNIOR, CARLINDO VIEIRA DA - FCF ; GEMPERLI, ROLF - FM ; SANTOS, SILVIA REGINA CAVANI JORGE - FCF ; LEVIN, ANNA SARA SHAFFERMAN - FM
- Unidades: FCF; FM
- DOI: 10.1016/j.clinthera.2017.06.008
- Subjects: ANTIBIÓTICOS; DOENÇAS INFECCIOSAS
- Language: Inglês
- Imprenta:
- Publisher place: Bridgewater
- Date published: 2017
- Source:
- Título: Clinical Therapeutics
- ISSN: 0149-2918
- Volume/Número/Paginação/Ano: v. 39, n. 8, p. 1649-1657, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MACHADO, Anna Silva et al. Clinical outcome and antimicrobial therapeutic drug monitoring for the treatment of infections in acute burn patients. Clinical Therapeutics, v. 39, n. 8, p. 1649-1657, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.clinthera.2017.06.008. Acesso em: 12 fev. 2026. -
APA
Machado, A. S., Oliveira, M. S., Sanches, C., Silva Junior, C. V. da, Gomez, D. S., Gemperli, R., et al. (2017). Clinical outcome and antimicrobial therapeutic drug monitoring for the treatment of infections in acute burn patients. Clinical Therapeutics, 39( 8), 1649-1657. doi:10.1016/j.clinthera.2017.06.008 -
NLM
Machado AS, Oliveira MS, Sanches C, Silva Junior CV da, Gomez DS, Gemperli R, Santos SRCJ, Levin ASS. Clinical outcome and antimicrobial therapeutic drug monitoring for the treatment of infections in acute burn patients [Internet]. Clinical Therapeutics. 2017 ; 39( 8): 1649-1657.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1016/j.clinthera.2017.06.008 -
Vancouver
Machado AS, Oliveira MS, Sanches C, Silva Junior CV da, Gomez DS, Gemperli R, Santos SRCJ, Levin ASS. Clinical outcome and antimicrobial therapeutic drug monitoring for the treatment of infections in acute burn patients [Internet]. Clinical Therapeutics. 2017 ; 39( 8): 1649-1657.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1016/j.clinthera.2017.06.008 - Imipenem in burn patients: pharmacokinetic profile and PK/PD target attainment
- PK/PD correlation for fluconazol effectiveness in burn patients
- PK/PD correlation for vancomycin effectiveness in burn children
- PK/PD correlation for carbopenem effectiveness in burn children
- A new carbapenem agent for the control of severe infection caused by the most agressive nosocomial strains in critically ill patients
- Imipenem pk/pd correlation for the control of pulmonary infection in critical burn patients with sepsis
- Pk/pd correlation for the control of infection by pseudomonas aeruginosa in critical burn patient: report case after electrical accident
- Imipenem serum measurements in real time for target attainment against more agressive strains MlC>2mg/l in septic burns
- Vancomycin prescription changes in real time based on drug plasma monitoring against Staphylococcus spp MlC 2mg/l in critically ill paediatric burns
- Triazoles or echinocandins antifungal therapy against candida glabrata in sepsis?
Informações sobre o DOI: 10.1016/j.clinthera.2017.06.008 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
